Study S000594

Exenatide Weekly Injections as an Adjunctive Treatment in Patients With Schizophrenia

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record Study Protocol (PDF)Statistical Analysis Plan (PDF)

Registration

Registration: NCT02417142
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: DOUBLE
Status: COMPLETED
Enrollment: 70
Start: 2014-09
Primary completion: 2019-07
Lead sponsor: University of Massachusetts, Worcester
Conditions: Schizophrenia; Schizoaffective Disorder
Interventions: DRUG:Exenatide; DRUG:Placebo
Results posted: TRUE

Registered primary outcomes

Negative Symptoms as Measured by the Scale for the Assessment of Negative Symptoms (SANS) Total Score [Baseline, Week 6, Week 12, Week 18 and Week 24]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.